BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 18, 2010
View Archived Issues
OncoMed Has 'Wnt' in its Sails; Bayer Deal Adds $40M Up Front
For a firm that has yet to reach Phase II with a lead program, OncoMed Pharmaceuticals Inc. has managed some pretty impressive feats in the past few years. (BioWorld Today)
Read More
Neurocrine in $235M Deal with Boehringer for GPR119 Agonists
Read More
Arginetix, Immune Control Merge Two Corridors in Vascular Space
Read More
Aquinox Raises $25M for Blood, Immune Disorders Molecule
Read More
EULAR Roundup
Read More
Stimuvax Hold Lifted in NSCLC; Oncothyreon, EMD Move Ahead
Read More
Stock Movers
Read More
Other News To Note
Read More
Clinic Roundup
Read More